William K. Warren, Jr. Frontiers in Neuroscience Conference
Laureate Psychiatric Clinic and Hospital Conference Center- October 21, 2015
8:00am - 9:00am Registration and Breakfast
9:00am - 10:00am Program
Dr. Daniel Pine is Chief, Section on Development and Affective Neuroscience, in the National Institute of Mental Health Intramural Research Program. Dr. Pine moved to this position in 2000, after 10 years of training, teaching, and research at Columbia University. Since graduating from medical school at the University of Chicago, Dr. Pine has been engaged continuously in research on pediatric mental disorders, as reflected in more than 400 peer-reviewed papers. Currently, his group examines the degree to which pediatric mood and anxiety disorders are associated with perturbed neural circuitry function. Dr. Pine served as the Chair of the Psychopharmacologic Drug Advisory Committee for the Food and Drug Administration, Chair of the Child and Adolescent Disorders Work Group for the DSM-5 Task Force, and President of the Society of Biological Psychiatry. He is a member of the Institute of Medicine of the National Academy of Sciences and has received many other awards.
Learning Objectives:
Laureate Psychiatric Clinic and Hospital Conference Center- October 21, 2015
8:00am - 9:00am Registration and Breakfast
9:00am - 10:00am Program
Dr. Daniel Pine is Chief, Section on Development and Affective Neuroscience, in the National Institute of Mental Health Intramural Research Program. Dr. Pine moved to this position in 2000, after 10 years of training, teaching, and research at Columbia University. Since graduating from medical school at the University of Chicago, Dr. Pine has been engaged continuously in research on pediatric mental disorders, as reflected in more than 400 peer-reviewed papers. Currently, his group examines the degree to which pediatric mood and anxiety disorders are associated with perturbed neural circuitry function. Dr. Pine served as the Chair of the Psychopharmacologic Drug Advisory Committee for the Food and Drug Administration, Chair of the Child and Adolescent Disorders Work Group for the DSM-5 Task Force, and President of the Society of Biological Psychiatry. He is a member of the Institute of Medicine of the National Academy of Sciences and has received many other awards.
Learning Objectives:
- understand the key phenomenological distinctions among the varied pediatric anxiety disorders
- understand the process through which clinical research on therapeutics is informed by basic research in systems neuroscience
- understand the direction in which ongoing research on therapeutics is moving, from basic research to novel applications through cognitive training.
RSS Feed